FCLR3 is associated with autoantibodies to IA-2 at diagnosis of Type 1 diabetes

被引：0
|
作者：
Fareed, R. [1 ]
Ye, J. [1 ]
Mortimer, G. [1 ]
Chipper-Keating, S. [1 ]
Chandler, K. [1 ]
Gillespie, K. M. [1 ]
Long, A. E. [1 ]
Williams, A. J. K. [1 ]
机构：
[1] Univ Bristol, Diabet & Metab, Sch Clin Sci, Bristol, Avon, England
来源：
DIABETIC MEDICINE | 2017年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A78
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [41] Analysis of the coding and promoter regions of the autoantigen IA-2 in subjects with and without autoantibodies to IA-2
    Cai, T
    Xie, JP
    She, JX
    Notkins, AL
    DIABETES, 2001, 50 (10) : 2406 - 2409
  • [42] Comparison of time-resolved immunofluorometric methods with radiobinding assay in the analysis of diabetes associated autoantibodies to GAD and IA-2 in children at genetic risk for type 1 diabetes
    不详
    ENDOCRINE JOURNAL, 2005, 52 : 53 - 53
  • [43] GAD65 and IA-2 autoantibodies are common in a subset of siblings of Sardinian Type 2 diabetes families
    Maioli, M
    Tonolo, G
    Bekris, L
    Cirillo, R
    Schranz, D
    Cossu, E
    Ciccarese, M
    Lernmark, Å
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 56 (01) : 41 - 47
  • [44] ZnT8, GAD 65 and IA-2 autoantibodies in type 1 diabetes children at diagnosis and 3-5 years after the diagnosis, stratified for residual beta cell function
    Sorensen, Jesper S.
    Sani, Fariba V.
    Pociot, Flemming
    Kristensen, Kurt
    Rix, Mariane
    Kjaersgaard, Per
    Hansen, Lars P.
    Ellermann, Annie
    Birkebaek, Niels H.
    HORMONE RESEARCH, 2009, 72 : 53 - 53
  • [45] GAD65 and IA-2 autoantibodies identify latent autoimmune diabetes of adulthood in phenotypic type 2 diabetes in Canadians
    Behme, MT
    Mahon, JL
    Dupre, J
    DIABETES, 2001, 50 : A258 - A258
  • [46] Cross reactivity between IA-2 and phogrin/IA-2 beta in binding of autoantibodies in IDDM
    Hatfield, ECI
    Hawkes, CJ
    Payton, MA
    Christie, MR
    DIABETOLOGIA, 1997, 40 (11) : 1327 - 1333
  • [47] GAD-65, but not IA-2 antibodies are associated with thyrogastric autoimmunity in type 1 diabetes.
    De Leeuw, I
    De Block, C
    Van Gaal, L
    Winnock, F
    Van Autrieve, J
    Gorus, F
    DIABETOLOGIA, 2000, 43 : A101 - A101
  • [48] New DELFIA assay for IA-2 autoantibodies
    Suonpaa, K
    Westerlund-Karlsson, A
    Hinkkanen, AE
    Suonpaa, M
    Repo, S
    Kankaanpaa, PE
    Ilonen, JS
    Knip, M
    Seppala, J
    DIABETES, 2002, 51 : A560 - A560
  • [49] The IA-2 intracellular fragment (a.n.761-964) is the most sensitive marker of IA-2 autoimmunity in type 1 diabetes
    Tiberti, C
    Yu, L
    Verrienti, A
    Di Giovanni, V
    Farilla, L
    Vecci, E
    Eisenbarth, GS
    Dotta, F
    Di Mario, U
    DIABETOLOGIA, 2001, 44 : A32 - A32
  • [50] IA-2 combined epitope assay: A new, highly sensitive approach to evaluate IA-2 humoral autoimmunity in type 1 diabetes
    Tiberti, C
    Verrienti, A
    Fiore, B
    Yu, LP
    Eisenbarth, GS
    Dotta, F
    Di Mario, U
    CLINICAL IMMUNOLOGY, 2005, 115 (03) : 260 - 267
12345